
IndraLab
Statements
Arachidonic acid activates KCNK2. 52 / 53
|
37
15
reach
"The present study showed that treatment of uterine strips with TREK-1 channel inhibitor L-methionine insignificantly increased uterine contraction, while treatment with TREK-1 activator arachidonic acid caused a dramatic reduction in uterine contraction, suggesting that the TREK-1 is active and functional during pregnancy in rats."
reach
"To further analyze the effects of pyrethroids in the K channels expressed in native neurons, we searched for small/medium-sized neurons, where arachidonic acid (a known activator of TREK-1, TREK-2, and TRAAK ) or cloxyquin (a TRESK-activating compound ) increased the current measured at hyperpolarized voltages in high extracellular K solution."
sparser
"Here, using murine forms of TREK-1 and TREK-2, we provide evidence that spadin is not a direct blocker of TREK-1 when expressed in heterologous systems but an antagonist, displaying no intrinsic activity, able to selectively prevent AA-activation of TREK-1 channels through an allosteric mechanism."
reach
"It is interesting to note that ALA (non-specific activator of TREK-1) or arachidonic acid (activator of TREK-1) increased CVSMCs whole-cell currents, which were blocked by selective blockers of large-conductance Ca-activated K+ channels in both wild-type and TREK-1 (gene name KCNK2) knockout mice [64]."
reach
"Importantly, in uterine strips treated simultaneously with progesterone and L-methionine, no significant reduction in uterine contraction was observed, and the uterine contraction was at levels similar to those in control tissues without progesterone or L-methionine treatment, suggesting opposing effects of L-methionine and progesterone on TREK-1 channel mediated uterine relaxation TREK-1 activator arachidonic acid causes no further effect on progesterone induced uterine relaxation."
sparser
"However, application of 1 μM spadin alone failed to inhibit mTREK-1-Y284A basal currents; 11.3 ± 1.9 μA (control) versus 11.3 ± 2.0 μA (spadin) ( xref ), and reinforces our suggestion that spadin is not a channel blocker of activated channels, but selectively and specifically antagonizes AA-activation of TREK-1 channels via an allosteric mechanism."
reach
"It is unlikely that block of phospholipase A underlies the substantive effects on TREK and TRESK channels seen here, because arachidonic acid enhances TREK (and TRAAK) channels (Fink et al., 1996; Enyedi and Czirják, 2010) and blocks TRESK channels (Sano et al., 2003; Kang et al., 2004)."
sparser
"However that spadin antagonizes AA activation of TREK-1 channels, and not that of DHA, suggests that AA activation of TREK-1 may involve a mechanism distinct from the C-terminal domain, interacting with other regions in TREK-1 or inducing its effects through interactions with the lipid bilayer ( xref )."